Nike NKE Q1 2026 Earnings EPS Surges Past Estimates with 2289 Beat NWN Q1 2026 Earnings EPS Misses Estimates Amidst Rising Costs and Weather Headwinds BEP Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline OCSL Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Credit Performance DSGN Q1 2026 Earnings Narrowed Loss Per Share Misses on Improved Operating Efficiency PNR Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher WMB Q1 2026 Earnings Modest EPS Miss Amid Positive Market Reaction MRAM Q1 2026 Earnings Earnings Per Share Beats Analyst Estimates by 19 AIN Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength MDU Q1 2026 Earnings EPS Misses Estimates by 72 Stock Gains 15 NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase QNTM Q4 2025 Earnings Loss Per Share Reported Shares Surge on Biotech Progress